Global market for classification of Products/Tools in Polymerase Chain Reaction (PCR) is projected to reach US$12 billion by 2020, growing at a CAGR of 10.1% during 2014-2020.

1. www.axisresearchmind.com | Copyright © 2015 | All Rights Reserved
POLYMERASE CHAIN REACTION (PCR)
- PRODUCTS/TOOLS, 2014-2020
GLOBAL TRENDS, ESTIMATES AND FORECASTS
PRICE: US$2640
NO. OF PAGES: 289
TABLES/CHARTS: 91
REPORT CODE: ARMMR168N.1
PUBLICATION: DECEMBER 2015

2. www.axisresearchmind.com | Copyright © 2015 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 2
POLYMERASE CHAIN REACTION (PCR) - PRODUCTS/TOOLS, 2014-2020
SEGMENTATION
POLYMERASE CHAIN REACTION (PCR) - PRODUCTS/TOOLS
The analysis primarily deals with major PCR product/tools market. Further, the
subdivided categories include:
 PCR PRODUCTS/TOOLS
o PCR MACHINES
o PCR REAGENTS
o PCR DETECTION KITS/ASSAYS
o CONSUMABLES PCR
o OTHER (SOFTWARE, PIPETTING ROBOT & ETC.,)
PCR PRODUCT/TOOLS - GLOBAL MARKET WATCH, 2014-
2020
With a CAGR of 10.1%, global market value for PCR Products/Tools market is anticipated
to be worth US$12 billion by 2020. On a global scale, Europe accounts for more than 25%
of the market. While USA accounts for the largest share of the global market value on a
country basis, Asia-Pacific is the fastest growing region in terms of growth rate
anticipated in the near future and leads the world.
PCR Machines account for the largest share of the entire market, driving a CAGR of 9.5%
during the analysis period 2014-2020. PCR Reagents and PCR Detection Kits/Assays
accounts for more than 40% of the market share and fastest growing segment with a
CAGR approximately 10.8% and 10.5% by 2020 respectively.
KEY COMPANIES PROFILED
Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., BD Biosciences, Bio-
Rad Laboratories, Inc., Complete Genomics, Inc., Epicentre® Biotechnologies, GE
Healthcare (Life Sciences), Illumina, Qiagen, Inc., Dna Landmarks, Inc., Roche
Diagnostics, Eppendorf AG, Cytocell Ltd, Shimadzu Biotech, Dnavision SA, Exiqon,
Hokkaido System Science Co., Ltd., Ocimum Biosolutions, Ltd., HY Laboratories LTD.,
PerkinElmer Life Sciences & many more….

3. www.axisresearchmind.com | Copyright © 2015 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 3
POLYMERASE CHAIN REACTION (PCR) - PRODUCTS/TOOLS, 2014-2020
REPORT FOCUS
The report “Polymerase Chain Reaction (PCR) - Products/Tools - Global Trends,
Estimates and Forecasts, 2014-2020” reviews the latest PCR market trends with a
perceptive attempt to disclose the near-
future growth prospects. An in-depth
analysis on a geographic basis provides
strategic business intelligence for life
science sector investments. The study
reveals profitable investment strategies
for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract
Research Organizations (CROs) and many more in preferred locations.
The report focuses on the current market trends, estimates and forecasts for the
period 2014-2020. More than 435 leading market players are identified and 45 key
companies that project improved market activities in the near future are profiled. The
report consists of 91 data charts describing
the market shares, sales forecasts and
growth prospects. Moreover, key strategic
activities in the market including
mergers/acquisitions, collaborations/partnerships, product launches/developments
are discussed.
GEOGRAPHIC COVERAGE
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases & published research reports are also used for estimates.
The market growth rate in the major economies such as the U.S., Japan, China etc.
are estimated individually.
The region wise distribution of the market consists of North America, Europe, Asia-Pacific,
Latin America and Rest of World with 14 countries, analyzed individually as follows:
NORTH AMERICA USA & CANADA
EUROPE
GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST
OF EUROPE
ASIA-PACIFIC JAPAN, CHINA, INDIA, SOUTH KOREA AND REST OF ASIA-PACIFIC
LATIN AMERICA BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA
REST OF THE WORLD -
Getting the most from our custom
research
Knowing Future by Analyzing the Market in
Key Growth Areas and New
Technologies…!!!
“Learn High Potential Market Dynamics
for Strategic Business Planning”

4. www.axisresearchmind.com | Copyright © 2015 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 4
POLYMERASE CHAIN REACTION (PCR) - PRODUCTS/TOOLS, 2014-2020
KEY INDUSTRY ACTIVITIES
 HITACHI HIGH-TECHNOLOGIES AND QIAGEN ENTER INTO LONG-TERM STRATEGIC
COLLABORATION FOR MOLECULAR TESTING
 EUROFINS STRENGTHENS ITS FOOTPRINT IN SPECIALTY CLINICAL DIAGNOSTICS WITH
THE ACQUISITION OF DIATHERIX LABORATORIES, INC. IN THE US
 PERKINELMER LAUNCHES FIRST FULLY AUTOMATED GENETIC DISORDER SCREENING
SYSTEM IN CHINA
 ABBOTT'S PIONEERING, INFECTIOUS DISEASE TESTING PLATFORM, IRIDICA, NOW
AVAILABLE IN EUROPE
 ROCHE RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR THE LIGHTMIX EBOLA
ZAIRE RRT-PCR TEST
 ROCHE UNVEILS MYCOTOOL REAL-TIME PCR KIT VALIDATION REPORT FOR IMPROVED
QUALITY CONTROL OF BIOPHARMACEUTICAL PRODUCTS
 ROCHE LAUNCHES PCR MOLECULAR DIAGNOSTIC SYSTEM FOR POINT OF CARE
ENVIRONMENT
 ROCHE DIAGNOSTICS PURCHASES TISSUE DISSECTION TECHNOLOGY FROM AVANSCI
BIO
 BECKMAN COULTER DIAGNOSTICS AND SEEGENE ANNOUNCE SUPPLY AGREEMENT
FOR MULTIPLEX REAGENTS FOR VERIS MOLECULAR DIAGNOSTICS SYSTEM
 AFFYMETRIX LAUNCHES SOLUTION TO ENABLE CANCER RESEARCHERS TO RAPIDLY
MAP THE FUNCTIONAL IMPACT OF DNA ALTERATIONS ON GENE EXPRESSION
PROFILES TO IDENTIFY POTENTIAL CANCER DRIVER EVENTS
 AFFYMETRIX EXCLUSIVELY LICENSES TECHNOLOGY FROM PEPTIDE GROOVE LLP FOR
HLA TYPING FROM GENOTYPING DATA
 AFFYMETRIX AND ARIOSA DIAGNOSTICS ANNOUNCE SIGNING OF MULTI-YEAR SUPPLY
AGREEMENT IN SUPPORT OF ARIOSA’S NON-INVASIVE PRENATAL TEST
 BIOFIRE DEFENSE, A BIOMÉRIEUX COMPANY, RECEIVES FAST-TRACK AUTHORIZATION
OF FILMARRAY® EBOLA TEST
 HEALTH CANADA APPROVES FIRST NEAR-PATIENT DNA TEST FOR PERSONALIZED
MEDICINE
 AGILENT TECHNOLOGIES INTRODUCES MIRNA MICROARRAYS FEATURING LATEST
MIRBASE 21 CONTENT
 MOBIDIAG ANNOUNCES CE-IVD MARKING OF AMPLIDIAG™ BACTERIAL GE FOR FAST
AND ACCURATE PCR-BASED DIAGNOSTICS OF GASTROENTERITIS TEST OPTIMIZES
SCREENING OF GASTROENTERITIS-CAUSING BACTERIA DIRECTLY FROM STOOL
SAMPLES
& many more….